Breaking News Instant updates and real-time market news.

MHK

Mohawk

$76.59 /

+6.06 (+8.59%)

17:26
07/13/20
07/13
17:26
07/13/20
17:26

Mohawk sinks 10% to $68.64 after announcing Class Action lawsuit

  • 07

    Aug

MHK Mohawk
$76.59 /

+6.06 (+8.59%)

07/10/20 Jefferies
Mohawk could see short-lived relief rally after flooring data, says Jefferies
07/09/20 Stifel
Stifel says 'difficult if not impossible to opine' on Mohawk allegations
07/09/20 JPMorgan
Allegations in lawsuit to create overhang on Mohawk shares, says JPMorgan
07/09/20 Truist
Mohawk quiet period hinders lawsuit response, says SunTrust

TODAY'S FREE FLY STORIES

Hot Stocks
Arcadia Biosciences announces collaboration with Corner Foods » 08:19
08/06/20
08/06
08:19
08/06/20
08:19
RKDA

Arcadia Biosciences

$3.72 /

-0.04 (-1.06%)

Arcadia Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RKDA Arcadia Biosciences
$3.72 /

-0.04 (-1.06%)

RKDA Arcadia Biosciences
$3.72 /

-0.04 (-1.06%)

RKDA Arcadia Biosciences
$3.72 /

-0.04 (-1.06%)

Recommendations
Tivity Health price target raised to $27 from $15 at Barrington » 08:18
08/06/20
08/06
08:18
08/06/20
08:18
TVTY

Tivity Health

$13.60 /

-0.05 (-0.37%)

Barrington analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TVTY Tivity Health
$13.60 /

-0.05 (-0.37%)

TVTY Tivity Health
$13.60 /

-0.05 (-0.37%)

07:00 Today Craig-Hallum
Tivity Health upgraded to Buy from Hold at Craig-Hallum
06/12/20 Guggenheim
Tivity Health initiated with a Neutral at Guggenheim
05/07/20 Barrington
Tivity Health price target lowered to $15 from $24 at Barrington
03/16/20 Craig-Hallum
Tivity Health price target lowered to $4 from $18 at Craig-Hallum
TVTY Tivity Health
$13.60 /

-0.05 (-0.37%)

TVTY Tivity Health
$13.60 /

-0.05 (-0.37%)

TVTY Tivity Health
$13.60 /

-0.05 (-0.37%)

TVTY Tivity Health
$13.60 /

-0.05 (-0.37%)

Earnings
Zosano Pharma reports Q2 EPS (14c), consensus (14c) » 08:18
08/06/20
08/06
08:18
08/06/20
08:18
ZSAN

Zosano Pharma

$1.34 /

+0.13 (+10.74%)

"Zosano is on the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZSAN Zosano Pharma
$1.34 /

+0.13 (+10.74%)

ZSAN Zosano Pharma
$1.34 /

+0.13 (+10.74%)

04/09/20 H.C. Wainwright
Zosano Pharma initiated with a Buy at H.C. Wainwright
11/15/19 BTIG
Zosano Pharma price target lowered to $16 from $19 at BTIG
11/15/19 Cantor Fitzgerald
Zosano Pharma price target lowered to $6 from $12 at Cantor Fitzgerald
ZSAN Zosano Pharma
$1.34 /

+0.13 (+10.74%)

Hot Stocks
Biocept announces pact with Aegea Biotechnologies » 08:17
08/06/20
08/06
08:17
08/06/20
08:17
BIOC

Biocept

$0.89 /

+0.1044 (+13.36%)

Biocept and Aegea…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIOC Biocept
$0.89 /

+0.1044 (+13.36%)

BIOC Biocept
$0.89 /

+0.1044 (+13.36%)

05/14/20 Brookline
Biocept initiated with a Buy at Brookline
  • 14
    Apr
Upgrade
Compass Point upgrades Square to Neutral on more resilience than expected » 08:17
08/06/20
08/06
08:17
08/06/20
08:17
SQ

Square

$146.46 /

+9.72 (+7.11%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SQ Square
$146.46 /

+9.72 (+7.11%)

SQ Square
$146.46 /

+9.72 (+7.11%)

05:24 Today Compass Point
Square upgraded to Neutral from Sell at Compass Point
08/05/20 RBC Capital
Square price target raised to $200 from $119 at RBC Capital
08/03/20 Deutsche Bank
Square price target raised to $140 from $120 at Deutsche Bank
07/22/20 Barclays
Square price target raised to $145 from $115 at Barclays
SQ Square
$146.46 /

+9.72 (+7.11%)

SQ Square
$146.46 /

+9.72 (+7.11%)

SQ Square
$146.46 /

+9.72 (+7.11%)

SQ Square
$146.46 /

+9.72 (+7.11%)

Upgrade
Maxar Technologies upgraded to Buy from Speculative Buy at TD Securities » 08:17
08/06/20
08/06
08:17
08/06/20
08:17
MAXR

Maxar Technologies

$20.74 /

+0.91 (+4.59%)

TD Securities analyst Tim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MAXR Maxar Technologies
$20.74 /

+0.91 (+4.59%)

MAXR Maxar Technologies
$20.74 /

+0.91 (+4.59%)

06/24/20 JPMorgan
Maxar Technologies price target raised to $20 from $16 at JPMorgan
01/15/20 Credit Suisse
Maxar Technologies upgraded to Neutral from Underperform at Credit Suisse
01/08/20 JPMorgan
Maxar Technologies price target raised to $25 from $15 at JPMorgan
12/30/19 Raymond James
Maxar Technologies downgraded to Market Perform from Outperform at Raymond James
MAXR Maxar Technologies
$20.74 /

+0.91 (+4.59%)

MAXR Maxar Technologies
$20.74 /

+0.91 (+4.59%)

MAXR Maxar Technologies
$20.74 /

+0.91 (+4.59%)

Earnings
Galmed reports Q2 EPS (26c), consensus (32c)  08:16
08/06/20
08/06
08:16
08/06/20
08:16
GLMD

Galmed

$4.91 /

+0.03 (+0.61%)

 
ShowHide Related Items >><<
GLMD Galmed
$4.91 /

+0.03 (+0.61%)

GLMD Galmed
$4.91 /

+0.03 (+0.61%)

05/22/20
Fly Intel: Top five analyst downgrades
05/22/20 B. Riley FBR
B. Riley FBR downgrades Galmed, cuts target to $8 from $11
05/22/20 B. Riley FBR
Galmed downgraded to Neutral from Buy at B. Riley FBR
05/15/20 H.C. Wainwright
Galmed price target lowered to $29 from $34 at H.C. Wainwright
GLMD Galmed
$4.91 /

+0.03 (+0.61%)

Hot Stocks
MeiraGTx expects cash to fund operating requirements into 2022 » 08:16
08/06/20
08/06
08:16
08/06/20
08:16
MGTX

MeiraGTx

$13.10 /

-0.08 (-0.61%)

As of June 30, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MGTX MeiraGTx
$13.10 /

-0.08 (-0.61%)

MGTX MeiraGTx
$13.10 /

-0.08 (-0.61%)

07/24/20 Piper Sandler
MeiraGTx shares offer 'great entry point,' says Piper Sandler
07/17/20 H.C. Wainwright
H.C. Wainwright says Applied Genetic still in 'pole position' in XLRP
07/17/20 Piper Sandler
MeiraGTx should be bought after XLRP data, says Piper Sandler
12/16/19 Piper Jaffray
MeiraGTx has most exciting Parkinson's disease program, says Piper Jaffray
MGTX MeiraGTx
$13.10 /

-0.08 (-0.61%)

  • 08
    Aug
Recommendations
HubSpot price target raised to $275 from $202 at Needham » 08:16
08/06/20
08/06
08:16
08/06/20
08:16
HUBS

HubSpot

$237.01 /

+7.31 (+3.18%)

Needham analyst Ryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUBS HubSpot
$237.01 /

+7.31 (+3.18%)

06:14 Today Piper Sandler
HubSpot price target raised to $300 from $200 at Piper Sandler
05:04 Today Jefferies
HubSpot price target raised to $285 from $202 at Jefferies
08/05/20 Wells Fargo
HubSpot price target raised to $200 from $155 at Wells Fargo
08/04/20 JPMorgan
HubSpot price target raised to $240 from $160 at JPMorgan
HUBS HubSpot
$237.01 /

+7.31 (+3.18%)

HUBS HubSpot
$237.01 /

+7.31 (+3.18%)

Earnings
MeiraGTx reports Q2 EPS (69c), consensus (46c) » 08:16
08/06/20
08/06
08:16
08/06/20
08:16
MGTX

MeiraGTx

$13.10 /

-0.08 (-0.61%)

Reports Q2 revenue $2.5M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MGTX MeiraGTx
$13.10 /

-0.08 (-0.61%)

MGTX MeiraGTx
$13.10 /

-0.08 (-0.61%)

07/24/20 Piper Sandler
MeiraGTx shares offer 'great entry point,' says Piper Sandler
07/17/20 H.C. Wainwright
H.C. Wainwright says Applied Genetic still in 'pole position' in XLRP
07/17/20 Piper Sandler
MeiraGTx should be bought after XLRP data, says Piper Sandler
12/16/19 Piper Jaffray
MeiraGTx has most exciting Parkinson's disease program, says Piper Jaffray
MGTX MeiraGTx
$13.10 /

-0.08 (-0.61%)

  • 08
    Aug
Earnings
DXP Enterprises reports Q2 EPS 12c, consensus 17c » 08:15
08/06/20
08/06
08:15
08/06/20
08:15
DXPE

DXP Enterprises

$18.93 /

+0.52 (+2.82%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DXPE DXP Enterprises
$18.93 /

+0.52 (+2.82%)

05/15/20 Sidoti
DXP Enterprises upgraded to Buy from Neutral at Sidoti
DXPE DXP Enterprises
$18.93 /

+0.52 (+2.82%)

General news
Jobless Claims to be reported at 08:30 » 08:15
08/06/20
08/06
08:15
08/06/20
08:15

Week of 8/1 Jobless…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
LiveXLive Media raises FY20 revenue view to $62.5M-$68.5M from $61.0M-$67.0M » 08:14
08/06/20
08/06
08:14
08/06/20
08:14
LIVX

LiveXLive Media

$3.13 /

-0.015 (-0.48%)

Consensus for FY20…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LIVX LiveXLive Media
$3.13 /

-0.015 (-0.48%)

LIVX LiveXLive Media
$3.13 /

-0.015 (-0.48%)

06/19/20 Alliance Global Partners
LiveXLive Media price target raised to $6 from $5.50 at Alliance Global Partners
06/19/20 Ladenburg
LiveXLive Media price target raised to $5.75 from $4.50 at Ladenburg
05/11/20 Alliance Global Partners
LiveXLive Media price target raised to $5.50 from $4 at Alliance Global Partners
04/16/20 Ladenburg
LiveXLive Media price target raised to $3.50 from $2.50 at Ladenburg
LIVX LiveXLive Media
$3.13 /

-0.015 (-0.48%)

LIVX LiveXLive Media
$3.13 /

-0.015 (-0.48%)

LIVX LiveXLive Media
$3.13 /

-0.015 (-0.48%)

Hot Stocks
Alexion appoints Uzair Qadeer as Chief Diversity Officer » 08:14
08/06/20
08/06
08:14
08/06/20
08:14
ALXN

Alexion

$102.68 /

-2.61 (-2.48%)

Alexion said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALXN Alexion
$102.68 /

-2.61 (-2.48%)

ALXN Alexion
$102.68 /

-2.61 (-2.48%)

07/31/20 SunTrust
Alexion price target raised to $155 from $135 at SunTrust
07/30/20 William Blair
Alexion downgraded to Market Perform from Outperform at William Blair
07/30/20 Piper Sandler
Alexion's guidance, buy back plans 'huge positives,' says Piper Sandler
07/20/20 Roth Capital
Apellis initiated with a Buy at Roth Capital
ALXN Alexion
$102.68 /

-2.61 (-2.48%)

ALXN Alexion
$102.68 /

-2.61 (-2.48%)

ALXN Alexion
$102.68 /

-2.61 (-2.48%)

ALXN Alexion
$102.68 /

-2.61 (-2.48%)

Earnings
Atlas Air sees Q3 revenue approx. $800M, consensus $729.93M  08:13
08/06/20
08/06
08:13
08/06/20
08:13
AAWW

Atlas Air

$57.71 /

+1.98 (+3.55%)

 
ShowHide Related Items >><<
AAWW Atlas Air
$57.71 /

+1.98 (+3.55%)

AAWW Atlas Air
$57.71 /

+1.98 (+3.55%)

06/08/20 Cowen
Atlas Air downgraded to Market Perform at Cowen
06/08/20 Cowen
Atlas Air downgraded to Market Perform from Outperform at Cowen
05/08/20 Stifel
Atlas Air price target raised to $50 from $37 at Stifel
04/21/20 Susquehanna
Atlas Air upgraded to Positive at Susquehanna
AAWW Atlas Air
$57.71 /

+1.98 (+3.55%)

AAWW Atlas Air
$57.71 /

+1.98 (+3.55%)

AAWW Atlas Air
$57.71 /

+1.98 (+3.55%)

Earnings
Global Partners reports Q2 EPS $2.17 vs. 36c last year » 08:13
08/06/20
08/06
08:13
08/06/20
08:13
GLP

Global Partners

$12.73 /

+0.44 (+3.58%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GLP Global Partners
$12.73 /

+0.44 (+3.58%)

GLP Global Partners
$12.73 /

+0.44 (+3.58%)

03/24/20 Barclays
Global Partners upgraded to Equal Weight from Underweight at Barclays
01/29/20 JPMorgan
JPMorgan downgrades four MLPs to Underweight from Neutral
01/29/20 JPMorgan
Global Partners downgraded to Underweight from Neutral at JPMorgan
01/07/20 Wells Fargo
Global Partners downgraded to Underweight at Wells Fargo
GLP Global Partners
$12.73 /

+0.44 (+3.58%)

Earnings
Ardelyx reports Q2 EPS (28c), consensus (26c) » 08:13
08/06/20
08/06
08:13
08/06/20
08:13
ARDX

Ardelyx

$5.72 /

+0.03 (+0.53%)

Reports Q2 revenue $1.8M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARDX Ardelyx
$5.72 /

+0.03 (+0.53%)

ARDX Ardelyx
$5.72 /

+0.03 (+0.53%)

04/09/20 Piper Sandler
Piper has 'meaningfully higher' conviction in Ardelyx after management calls
03/09/20 Piper Sandler
Ardelyx remains a top pick after 'quiet' Q4 at Piper Sandler
02/18/20 Jefferies
Ardelyx assumed with a Buy at Jefferies
02/12/20
Fly Intel: Top five analyst initiations
ARDX Ardelyx
$5.72 /

+0.03 (+0.53%)

  • 05
    Dec
ARDX Ardelyx
$5.72 /

+0.03 (+0.53%)

Earnings
Atlas Air sees FY20 revenue over $3B, consensus $2.95B  08:13
08/06/20
08/06
08:13
08/06/20
08:13
AAWW

Atlas Air

$57.71 /

+1.98 (+3.55%)

 
ShowHide Related Items >><<
AAWW Atlas Air
$57.71 /

+1.98 (+3.55%)

AAWW Atlas Air
$57.71 /

+1.98 (+3.55%)

06/08/20 Cowen
Atlas Air downgraded to Market Perform at Cowen
06/08/20 Cowen
Atlas Air downgraded to Market Perform from Outperform at Cowen
05/08/20 Stifel
Atlas Air price target raised to $50 from $37 at Stifel
04/21/20 Susquehanna
Atlas Air upgraded to Positive at Susquehanna
AAWW Atlas Air
$57.71 /

+1.98 (+3.55%)

AAWW Atlas Air
$57.71 /

+1.98 (+3.55%)

AAWW Atlas Air
$57.71 /

+1.98 (+3.55%)

Downgrade
Inseego downgraded to Market Perform from Outperform at Northland » 08:13
08/06/20
08/06
08:13
08/06/20
08:13
INSG

Inseego

$14.76 /

+0.23 (+1.58%)

Northland analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INSG Inseego
$14.76 /

+0.23 (+1.58%)

INSG Inseego
$14.76 /

+0.23 (+1.58%)

07:59 Today Roth Capital
Inseego downgraded to Neutral from Buy at Roth Capital
06/25/20 Stifel
Inseego initiated with a Buy at Stifel
05/19/20 Cowen
Inseego price target raised to $13.50 from $12 at Cowen
04/30/20 Vertical Group
Inseego initiated with a Sell at Vertical Group
INSG Inseego
$14.76 /

+0.23 (+1.58%)

INSG Inseego
$14.76 /

+0.23 (+1.58%)

INSG Inseego
$14.76 /

+0.23 (+1.58%)

Earnings
Atlas Air reports Q2 adj. EPS $4.71, consensus $2.13 » 08:12
08/06/20
08/06
08:12
08/06/20
08:12
AAWW

Atlas Air

$57.71 /

+1.98 (+3.55%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AAWW Atlas Air
$57.71 /

+1.98 (+3.55%)

AAWW Atlas Air
$57.71 /

+1.98 (+3.55%)

06/08/20 Cowen
Atlas Air downgraded to Market Perform at Cowen
06/08/20 Cowen
Atlas Air downgraded to Market Perform from Outperform at Cowen
05/08/20 Stifel
Atlas Air price target raised to $50 from $37 at Stifel
04/21/20 Susquehanna
Atlas Air upgraded to Positive at Susquehanna
AAWW Atlas Air
$57.71 /

+1.98 (+3.55%)

AAWW Atlas Air
$57.71 /

+1.98 (+3.55%)

AAWW Atlas Air
$57.71 /

+1.98 (+3.55%)

Earnings
U.S. Physical Therapy reports Q2 EPS ex-items 39c, consensus (18c) » 08:12
08/06/20
08/06
08:12
08/06/20
08:12
USPH

U.S. Physical Therapy

$90.02 /

+4.99 (+5.87%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
USPH U.S. Physical Therapy
$90.02 /

+4.99 (+5.87%)

USPH U.S. Physical Therapy
$90.02 /

+4.99 (+5.87%)

06/08/20 Barrington
U.S. Physical Therapy price target raised to $95 from $84 at Barrington
04/30/20 Sidoti
U.S. Physical Therapy downgraded to Neutral following run-up at Sidoti
04/30/20 Sidoti
U.S. Physical Therapy downgraded to Neutral from Buy at Sidoti
03/11/20 Sidoti
U.S. Physical Therapy upgraded to Buy from Neutral at Sidoti
USPH U.S. Physical Therapy
$90.02 /

+4.99 (+5.87%)

Earnings
Stealth Biotherapeutics reports Q2 EPS (2c), consensus (2c) » 08:11
08/06/20
08/06
08:11
08/06/20
08:11
MITO

Stealth Biotherapeutics

$2.01 /

-0.05 (-2.43%)

"The clinical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MITO Stealth Biotherapeutics
$2.01 /

-0.05 (-2.43%)

MITO Stealth Biotherapeutics
$2.01 /

-0.05 (-2.43%)

04/14/20 Roth Capital
Stealth Biotherapeutics initiated with a Buy at Roth Capital
04/03/20 Nomura Instinet
Stealth Biotherapeutics price target lowered to $10 from $14 at Nomura Instinet
04/02/20 BMO Capital
Stealth Biotherapeutics price target lowered to $3 from $7 at BMO Capital
04/02/20 H.C. Wainwright
Stealth Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
MITO Stealth Biotherapeutics
$2.01 /

-0.05 (-2.43%)

Earnings
LiveXLive Media reports Q1 EPS (13c), consensus (11c) » 08:11
08/06/20
08/06
08:11
08/06/20
08:11
LIVX

LiveXLive Media

$3.13 /

-0.015 (-0.48%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LIVX LiveXLive Media
$3.13 /

-0.015 (-0.48%)

LIVX LiveXLive Media
$3.13 /

-0.015 (-0.48%)

06/19/20 Alliance Global Partners
LiveXLive Media price target raised to $6 from $5.50 at Alliance Global Partners
06/19/20 Ladenburg
LiveXLive Media price target raised to $5.75 from $4.50 at Ladenburg
05/11/20 Alliance Global Partners
LiveXLive Media price target raised to $5.50 from $4 at Alliance Global Partners
04/16/20 Ladenburg
LiveXLive Media price target raised to $3.50 from $2.50 at Ladenburg
LIVX LiveXLive Media
$3.13 /

-0.015 (-0.48%)

LIVX LiveXLive Media
$3.13 /

-0.015 (-0.48%)

LIVX LiveXLive Media
$3.13 /

-0.015 (-0.48%)

Earnings
Donaldson sees Q4 sales down approximately 15% year-over-year » 08:10
08/06/20
08/06
08:10
08/06/20
08:10
DCI

Donaldson

$50.65 /

+1.05 (+2.12%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DCI Donaldson
$50.65 /

+1.05 (+2.12%)

DCI Donaldson
$50.65 /

+1.05 (+2.12%)

06/26/20 Morgan Stanley
Donaldson initiated with an Overweight at Morgan Stanley
03/23/20 Jefferies
Jefferies downgrades 10 'lower conviction' Chemicals stocks to Hold
03/23/20 Jefferies
Donaldson downgraded to Hold from Buy at Jefferies
DCI Donaldson
$50.65 /

+1.05 (+2.12%)

Earnings
Pacira reports preliminary July sales of Exparel of $38.1M » 08:10
08/06/20
08/06
08:10
08/06/20
08:10
PCRX

Pacira

$56.09 /

+0.83 (+1.50%)

Pacira reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PCRX Pacira
$56.09 /

+0.83 (+1.50%)

PCRX Pacira
$56.09 /

+0.83 (+1.50%)

07/13/20 H.C. Wainwright
Pacira price target raised to $68 from $63 at H.C. Wainwright
07/10/20 Jefferies
Pacira price target raised to $69 from $53 at Jefferies
07/06/20 Needham
Pacira price target raised to $64 from $52 at Needham
07/06/20 Piper Sandler
Pacira price target raised to $65 from $49 at Piper Sandler
PCRX Pacira
$56.09 /

+0.83 (+1.50%)

PCRX Pacira
$56.09 /

+0.83 (+1.50%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.